Bo‐Gen Ye
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 10%
- Immune cells in cancer
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Immune cells in cancer 3
- Co-authors
- Hui‐Chuan Sun (9 shared papers)Zong‐Tao Chai (8 shared papers)Xiao‐Dong Zhu (8 shared papers)Hao Cai (8 shared papers)Jian‐Yang Ao (7 shared papers)De-Ning Ma (5 shared papers)Ling–Qun Kong (3 shared papers)Ning Zhang (2 shared papers)
- Journals
- Journal of Hematology & Oncology (2 papers)Cancer Letters (1 paper)Molecular Cancer Therapeutics (1 paper)Tumor Biology (1 paper)Oncotarget (1 paper)
- Partner nations
- China
In The Last Decade
Bo‐Gen Ye
9 papers receiving 565 citations
Peers
Comparison fields: 5 of 55
- Hepatology 88
- Immunology 156
- Cancer Research 99
- Oncology 98
- Immunology and Allergy 11
Countries citing papers authored by Bo‐Gen Ye
This map shows the geographic impact of Bo‐Gen Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Gen Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Gen Ye more than expected).
Fields of papers citing papers by Bo‐Gen Ye
This network shows the impact of papers produced by Bo‐Gen Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Gen Ye. The network helps show where Bo‐Gen Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo‐Gen Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 161 | |
| 2 | 2016 | 109 | |
| 3 | 2018 | 79 | |
| 4 | 2015 | 77 | |
| 5 | 2017 | 67 | |
| 6 | Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. | 2017 | 30 |
| 7 | 2015 | 25 | |
| 8 | 2016 | 16 | |
| 9 | 2018 | 11 |
About Bo‐Gen Ye
Bo‐Gen Ye is a scholar working on Hepatology, Immunology, Cancer Research, Oncology and Immunology and Allergy, having authored 9 papers that have together received 575 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), MicroRNA in disease regulation (2 papers), Cancer Cells and Metastasis (2 papers), Angiogenesis and VEGF in Cancer (2 papers), S100 Proteins and Annexins (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Hepatology (88 citations), Immunology (156 citations), Cancer Research (99 citations), Oncology (98 citations) and Immunology and Allergy (11 citations). Bo‐Gen Ye has collaborated with scholars based in China. Frequent co-authors include Hui‐Chuan Sun, Zong‐Tao Chai, Xiao‐Dong Zhu, Hao Cai, Jian‐Yang Ao, De-Ning Ma, Ling–Qun Kong, Ning Zhang, Yuanyuan Zhang and Dongmei Gao. Their work appears in journals such as Journal of Hematology & Oncology, Cancer Letters, Molecular Cancer Therapeutics, Tumor Biology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.